- ICH GCP
- Amerikanska kliniska prövningsregistret
- Klinisk prövning NCT03121157
Detroit Young Adult Asthma Project (DYAAP)
5 maj 2022 uppdaterad av: Karen MacDonell, PhD, Wayne State University
Multi-component Technology Intervention for African American Emerging Adults With Asthma
The purpose of the Detroit Young Adult Asthma Project is to test a technology based program to help African American young adults learn to better manage their asthma.
Participants will be randomized to a multi-component technology-based intervention (MCTI) targeting asthma medication adherence or to a comparison control condition.
Studieöversikt
Status
Aktiv, inte rekryterande
Betingelser
Intervention / Behandling
Detaljerad beskrivning
Racial and ethnic minority youth have poorer asthma status than Caucasian youth, even after controlling for socioeconomic variables.
Proper use of asthma controller medications is critical in reducing asthma mortality and morbidity.
The clinical consequences of poor asthma management include increased illness complications, excessive functional morbidity, and fatal asthma attacks.
There are significant limitations in research on interventions to improve asthma management in racial minority populations, particularly minority adolescents and young adults, though illness management tends to deteriorate after adolescence during emerging adulthood, the unique developmental period beyond adolescence but before adulthood.
All elements of the proposed study protocol were piloted in an NHLBI-funded pilot study (1R34HL107664-01A1 MacDonell).
Results suggested feasibility and acceptability of the study protocol as well as proof of concept.
The intervention is now being tested in a larger randomized clinical trial.
The proposed study will include 192 African American emerging adults with moderate to severe persistent asthma and low controller medication adherence recruited from clinic and emergency department settings.
Half of the sample will be randomized to receive a multi-component technology-based intervention (MCTI) targeting adherence to daily controller medication.
The MCTI consists of two components: 1) 2 sessions of computer-delivered motivational interviewing targeting medication adherence, and 2) individualized text messaging focused on medication adherence between the sessions.
Text messages will be individualized based on Ecological Momentary Assessment (EMA).
The remaining half of participants will complete a series of computer-delivered asthma education modules matched for length, location, and method of delivery of the intervention session.
Control participants will also receive text messages between intervention sessions.
Message content will be the same for all control participants and contain general facts about asthma (not tailored).
Youth will be recruited from the Detroit Medical Center, the only university affiliated medical center in Detroit, Michigan.
It is hypothesized that youth randomized to MCTI will show improvements in adherence to medication (primary outcome) and asthma control (secondary outcome) compared to the comparison condition at all post-intervention follow ups (3, 6, 9, and 12 months).
Studietyp
Interventionell
Inskrivning (Förväntat)
192
Fas
- Inte tillämpbar
Kontakter och platser
Det här avsnittet innehåller kontaktuppgifter för dem som genomför studien och information om var denna studie genomförs.
Studieorter
-
-
Michigan
-
Detroit, Michigan, Förenta staterna, 48201
- Detroit Medical Center/Wayne State University School of Medicine
-
-
Deltagandekriterier
Forskare letar efter personer som passar en viss beskrivning, så kallade behörighetskriterier. Några exempel på dessa kriterier är en persons allmänna hälsotillstånd eller tidigare behandlingar.
Urvalskriterier
Åldrar som är berättigade till studier
18 år till 29 år (Vuxen)
Tar emot friska volontärer
Nej
Kön som är behöriga för studier
Allt
Beskrivning
Inclusion Criteria:
- African American, moderate to severe persistent asthma requiring daily controller medications, live within 30 miles of study site (Detroit area), be able to complete questionnaires in English, must own or have access to a cell for phone for study duration.
Exclusion Criteria:
- Thought disorder (i.e. schizophrenia, autism), suicidality, or mental retardation, youth with other chronic health conditions or pregnancy requiring ongoing medical intervention (e.g., HIV, Type II Diabetes).
Studieplan
Det här avsnittet ger detaljer om studieplanen, inklusive hur studien är utformad och vad studien mäter.
Hur är studien utformad?
Designdetaljer
- Primärt syfte: Förebyggande
- Tilldelning: Randomiserad
- Interventionsmodell: Parallellt uppdrag
- Maskning: Ingen (Open Label)
Vapen och interventioner
Deltagargrupp / Arm |
Intervention / Behandling |
---|---|
Experimentell: Intervention
The intervention group will receive two sessions of computer-delivered motivational interviewing via CIAS software programmed to target adherence to medications.
The intervention group will also receive text messaged adherence reminders between sessions.
Both the computer-delivered sessions and text messages will be tailored to the participant using ecological momentary assessment.
|
The intervention group receives two sessions of computer-delivered MI via software programmed to target adherence to medications and text messaged adherence reminders between sessions.
Sessions are provided by an avatar.
The intervention engages the youth with the avatar's communication of empathy, optimism, and autonomy support.
The intervention focuses the youth on adherence and relevant health behaviors with feedback on adherence, asthma symptoms, and tailored education.
Participants are guided in the planning process through goal setting activities.
The length of the intervention sessions are about 30 minutes each, with the total duration of the visit (assessment and intervention) lasting about 1.5 hours.
Andra namn:
|
Inget ingripande: Control
Control participants complete CIAS-delivered asthma education modules matched for length, location, and method of delivery of the intervention session.
Control participants complete each module at their own pace and then complete a short quiz to assess their knowledge.
Control participants also receive text messages between intervention sessions.
Message content is the same for all control participants and contains general facts about asthma (not tailored).
Message timing is not tailored and is sent at the same time every day (4:00 PM--time chosen to avoid AM and PM medication times but to not interfere with sleep and school activities).
|
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
---|---|---|
Medication Adherence
Tidsram: Change from baseline at 3, 6, and 12 months
|
Daily text messaging, Doser, and self-report
|
Change from baseline at 3, 6, and 12 months
|
Sekundära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
---|---|---|
Asthma Control
Tidsram: Change from baseline at 3, 6, and 12 months
|
Frequency of asthma symptoms based on self-report
|
Change from baseline at 3, 6, and 12 months
|
Asthma Control
Tidsram: Change from baseline at 3, 6, and 12 months
|
Lung functioning as measured by portable spirometer
|
Change from baseline at 3, 6, and 12 months
|
Samarbetspartners och utredare
Det är här du hittar personer och organisationer som är involverade i denna studie.
Sponsor
Samarbetspartners
Publikationer och användbara länkar
Den som ansvarar för att lägga in information om studien tillhandahåller frivilligt dessa publikationer. Dessa kan handla om allt som har med studien att göra.
Studieavstämningsdatum
Dessa datum spårar framstegen för inlämningar av studieposter och sammanfattande resultat till ClinicalTrials.gov. Studieposter och rapporterade resultat granskas av National Library of Medicine (NLM) för att säkerställa att de uppfyller specifika kvalitetskontrollstandarder innan de publiceras på den offentliga webbplatsen.
Studera stora datum
Studiestart (Faktisk)
10 april 2017
Primärt slutförande (Faktisk)
16 februari 2022
Avslutad studie (Förväntat)
30 juni 2022
Studieregistreringsdatum
Först inskickad
6 mars 2017
Först inskickad som uppfyllde QC-kriterierna
13 april 2017
Första postat (Faktisk)
20 april 2017
Uppdateringar av studier
Senaste uppdatering publicerad (Faktisk)
9 maj 2022
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
5 maj 2022
Senast verifierad
1 maj 2022
Mer information
Termer relaterade till denna studie
Ytterligare relevanta MeSH-villkor
Andra studie-ID-nummer
- 1R01HL133506-01 (U.S.S. NIH-anslag/kontrakt)
- R01HL133506 (U.S.S. NIH-anslag/kontrakt)
Plan för individuella deltagardata (IPD)
Planerar du att dela individuella deltagardata (IPD)?
NEJ
Läkemedels- och apparatinformation, studiedokument
Studerar en amerikansk FDA-reglerad läkemedelsprodukt
Nej
Studerar en amerikansk FDA-reglerad produktprodukt
Nej
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .
Kliniska prövningar på Multi-Component Technology Based Intervention
-
The University of Texas Health Science Center,...National Center for Advancing Translational Sciences (NCATS)Aktiv, inte rekryterande
-
VA Office of Research and DevelopmentRekryteringÄldre män och kvinnor med hög fallriskFörenta staterna
-
Mayo ClinicNational Institute on Aging (NIA); Innovative Design LabsAvslutadLändryggssmärtaFörenta staterna
-
Emory UniversityNational Institute on Minority Health and Health Disparities (NIMHD)Avslutad
-
Washington University School of MedicineSpinal Cord Injury/Disease Research ProgramAvslutad
-
Amasya UniversityAvslutadÅngest | GraviditetsrelateradKalkon
-
Amasya UniversityAvslutadPåfrestning | Graviditet, hög riskKalkon
-
University of PaviaUniversità degli Studi di BresciaAvslutadMentalt välbefinnandeItalien
-
Stockholm UniversityKarolinska Institutet; Region Stockholm; Centrum för kompetensutveckling... och andra samarbetspartnersAktiv, inte rekryterande
-
University of PittsburghNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) och andra samarbetspartnersAvslutadHemodialys | Njursjukdom i slutskedetFörenta staterna